CA2957900C - Amphiphilic block copolymers for delivery of active agents - Google Patents

Amphiphilic block copolymers for delivery of active agents Download PDF

Info

Publication number
CA2957900C
CA2957900C CA2957900A CA2957900A CA2957900C CA 2957900 C CA2957900 C CA 2957900C CA 2957900 A CA2957900 A CA 2957900A CA 2957900 A CA2957900 A CA 2957900A CA 2957900 C CA2957900 C CA 2957900C
Authority
CA
Canada
Prior art keywords
micelles
hydrophobic
controlled release
copolymer
release system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2957900A
Other languages
English (en)
French (fr)
Other versions
CA2957900A1 (en
Inventor
Wilhelmus Everhardus Hennink
Yang Shi
Cornelus Franciscus Van Nostrum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RWTH Aachen University
Original Assignee
RWTH Aachen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RWTH Aachen University filed Critical RWTH Aachen University
Publication of CA2957900A1 publication Critical patent/CA2957900A1/en
Application granted granted Critical
Publication of CA2957900C publication Critical patent/CA2957900C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Graft Or Block Polymers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2957900A 2014-08-11 2015-08-11 Amphiphilic block copolymers for delivery of active agents Active CA2957900C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2013317 2014-08-11
NL2013317A NL2013317B1 (en) 2014-08-11 2014-08-11 Amphiphilic block copolymers for delivery of active agents.
PCT/NL2015/050574 WO2016024861A1 (en) 2014-08-11 2015-08-11 Amphiphilic block copolymers for delivery of active agents

Publications (2)

Publication Number Publication Date
CA2957900A1 CA2957900A1 (en) 2016-02-18
CA2957900C true CA2957900C (en) 2023-06-13

Family

ID=51660570

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2957900A Active CA2957900C (en) 2014-08-11 2015-08-11 Amphiphilic block copolymers for delivery of active agents

Country Status (8)

Country Link
US (1) US11007148B2 (enExample)
EP (1) EP3191534B1 (enExample)
JP (1) JP6837962B2 (enExample)
CN (1) CN107106693B (enExample)
AU (1) AU2015302410B2 (enExample)
CA (1) CA2957900C (enExample)
NL (1) NL2013317B1 (enExample)
WO (1) WO2016024861A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4175966A1 (en) 2020-07-06 2023-05-10 Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen Polymeric micelles comprising glucuronide-prodrugs
WO2023044389A1 (en) 2021-09-15 2023-03-23 Gelmedix, Inc. Gelma polymer compositions comprising corticosteroids
IL311339A (en) 2021-09-15 2024-05-01 Gelmedix Inc Gelma polymer compositions and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425581B2 (en) * 1999-07-30 2008-09-16 Universiteit Utrecht Temperature sensitive polymers
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
US20050158271A1 (en) * 2000-10-11 2005-07-21 Lee Sang C. Pharmaceutical applications of hydrotropic polymer micelles
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
GB0131112D0 (en) 2001-12-31 2002-02-13 Univ London Pharmacy Block copolymers
JP2011515504A (ja) 2008-01-25 2011-05-19 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー ニッケルまたはニッケル合金を含むインクジェットプリントヘッドに用いる改善された耐食性を有するインクジェットインク
US20110281934A1 (en) * 2008-11-06 2011-11-17 Phaserx, Inc. Micelles of hydrophilically shielded membrane-destabilizing copolymers
US8299178B2 (en) * 2009-03-25 2012-10-30 National Tsing Hua University Stable micelles formed with diblock copolymers of critical micelle concentration copolymer and temperature-sensitive copolymer
JP5679253B2 (ja) * 2009-05-26 2015-03-04 国立大学法人東京工業大学 自立性高分子薄膜
US8470891B2 (en) 2009-12-23 2013-06-25 International Business Machines Corporation Biodegradable block polymers for drug delivery, and methods related thereto
JP5864837B2 (ja) * 2010-03-24 2016-02-17 セイコーエプソン株式会社 光重合性ポリマーミセルを含む記録液、及び記録液に用いる光重合性ポリマーミセルの製造方法
ES2391187B1 (es) * 2011-04-26 2013-10-18 Consejo Superior De Investigaciones Científicas (Csic) Compuestos poliméricos bioactivos nanoestructurados derivados de fármacos antiinflamatorios no esteroideos (aine) e imidazol.
ES1075003Y (es) * 2011-06-16 2011-10-10 Antimo Juan Manuel Cuartero Recuperador de calor

Also Published As

Publication number Publication date
US11007148B2 (en) 2021-05-18
JP2017524791A (ja) 2017-08-31
CA2957900A1 (en) 2016-02-18
WO2016024861A1 (en) 2016-02-18
AU2015302410B2 (en) 2019-01-17
NL2013317B1 (en) 2016-09-21
CN107106693A (zh) 2017-08-29
US20170231908A1 (en) 2017-08-17
EP3191534A1 (en) 2017-07-19
EP3191534C0 (en) 2025-10-01
EP3191534B1 (en) 2025-10-01
AU2015302410A1 (en) 2017-03-09
JP6837962B2 (ja) 2021-03-03
CN107106693B (zh) 2021-08-24

Similar Documents

Publication Publication Date Title
Qian et al. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma
US8747904B2 (en) Polymeric micelles for polynucleotide encapsulation
Tsai et al. Graft and diblock copolymer multifunctional micelles for cancer chemotherapy and imaging
Yu et al. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin
Cheng et al. Surface-fluorinated and pH-sensitive carboxymethyl chitosan nanoparticles to overcome biological barriers for improved drug delivery in vivo
Li et al. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA
Zhu et al. Paclitaxel-loaded poly (N-vinylpyrrolidone)-b-poly (ε-caprolactone) nanoparticles: preparation and antitumor activity in vivo
Wang et al. Functionalized micelles from block copolymer of polyphosphoester and poly (ɛ-caprolactone) for receptor-mediated drug delivery
Gao et al. PSMA-mediated endosome escape-accelerating polymeric micelles for targeted therapy of prostate cancer and the real time tracing of their intracellular trafficking
CN108542885B (zh) 抗肿瘤药物及其制备方法
US11857634B2 (en) Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids
CN109381705B (zh) 具有不对称膜结构的可逆交联生物可降解聚合物囊泡及其制备方法
Kim et al. Poly (β-amino ester) polymer library with monomer variation for mRNA delivery
Hao et al. Synthesis of an acid-cleavable and fluorescent amphiphilic block copolymer as a combined delivery vector of DNA and doxorubicin
WO2022052413A1 (zh) 具有不对称膜结构的载药聚合物囊泡及其制备方法与在制备治疗急性髓系白血病药物中的应用
WO2011058776A1 (ja) ブロックコポリマー、ブロックコポリマー－金属錯体複合体、及びそれを用いた中空構造体キャリア
AU2014332069B2 (en) Self-assembled brush block copolymer-nanoparticles for drug delivery
US20200140448A1 (en) Temozolomide compounds, polymers prepared therefrom, and method of treating a disease
Heck et al. Polymerizable 2-propionic-3-methylmaleic anhydrides as a macromolecular carrier platform for pH-responsive immunodrug delivery
AU2015302410B2 (en) Amphiphilic block copolymers for delivery of active agents
CN109762099B (zh) 一种聚合物-抗肿瘤药物偶联物及其制备方法和用途
Chen et al. Fabrication of dual pH/reduction-responsive P (CL-co-ACL)-based cross-linked polymeric micelles for PTX delivery
CN108126210B (zh) 一种单靶向还原响应囊泡纳米药物在制备脑肿瘤治疗药物中的应用
CN104721831A (zh) 一种透明质酸共价连接靶向性穿膜肽和活性药物的水溶性前药及其制备方法
CN107998081B (zh) 囊泡纳米药物在制备脑肿瘤治疗药物中的应用

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20200728